Home › Chronic Lymphocytic Leukemia › Arizona › Scottsdale
Chronic Lymphocytic Leukemia clinical trials in Scottsdale, AZ
5 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Scottsdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Honor Health Research Institute, Scottsdale
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RecruitingPhase 2
- Mayo Clinic in Arizona, Scottsdale
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RecruitingPhase 1/2
- Honor Health, Scottsdale
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
RecruitingHealthy volunteers welcome
- Mayo Clinic in Arizona, Scottsdale
Q702 for the Treatment of Patients With Hematologic Malignancies
RecruitingPhase 1
- Mayo Clinic in Arizona, Scottsdale
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN18 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
- Cincinnati, OH14 studies
Other studies in Scottsdale
- Breast Cancer18 studies
- Cancer (all types)18 studies
- Metastatic Cancer17 studies
- Prostate Cancer17 studies
- Colorectal Cancer16 studies
- Non-Small Cell Lung Cancer15 studies
- Pancreatic Cancer13 studies
- Melanoma10 studies
- Ulcerative Colitis8 studies
- Lung Cancer8 studies
- Liver Cancer (Hepatocellular Carcinoma)7 studies
- Alzheimer's Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.